Table 1.
ADAMTS | Disease/condition | Pro-/Anti-inflammatory | Mouse modela | Cell typeb | Substratec |
---|---|---|---|---|---|
ADAMTS1 | Aortic aneurysm and dissections [40,41,43,44] | Pro/Anti | Inducible whole-body knockout [43], Constitutive whole-body heterozygous [44] | Versican [40,41] | |
Atherosclerosis [31,35,36] | Pro/Anti | THP-1, macrophages [30,31] | Versican [35] | ||
LPS-induced inflammation [7,25] | Pro | ||||
Regulation of immune populations [21] | n.d. | Constitutive whole-body knockout [21] | Versican [21] | ||
ADAMTS2 | Dermatitis and skin dysfunction [[51], [52], [53]] | Anti | Constitutive whole-body knockout [52] | Monocytes, macrophages [53] | |
ADAMTS4 | Aortic aneurysm and dissections [40,42] | Pro | Constitutive whole-body knockout [42] | Versican [40,42] | |
Atherosclerosis [[30], [31], [32],34] | Pro | Constitutive whole-body knockout [34] | THP-1, macrophages [30,31] | Versican [32,34] | |
Ischemic stroke and CNS disorders [45] | Anti | ||||
Osteoarthritis [54] | Pro | Aggrecan [54] | |||
ADAMTS5 | Atherosclerosis [30,31] | n.d. | THP-1, macrophages [30,31] | ||
Influenza virus infection [60] | Pro | Constitutive whole-body knockout [60] | Versican [60] | ||
Osteoarthritis [[54], [55], [56], [57]] | Pro | Aggrecan [57] | |||
ADAMTS7 | Atherosclerosis [30,33,37,38] | Pro | Constitutive whole-body knockout [38] | THP-1, Macrophages [30,33] | |
ADAMTS8 | Atherosclerosis [30] | Pro | THP-1 [30] | ||
ADAMTS9 | Atherosclerosis [30] | Pro | THP-1 [30] | ||
ADAMTS12 | Asthma or allergy [27] | Anti | Constitutive whole-body knockout [27] | ||
Inflammatory response [26] | Anti | Constitutive whole-body knockout [26] | |||
Osteoarthritis and rheumatoid arthritis [58,59] | Pro | COMP [58] | |||
ADAMTS13 | Autoimmune encephalomyelitis [62] | Anti | |||
Multiple sclerosis [61] | Anti | ||||
Thrombotic thrombocytopenic purpura [47,50] | Anti | Von Willebrand Factor [47] | |||
Traumatic microvascular injury [48] | n.d. | Constitutive whole-body knockout [49] | Von Willebrand Factor [48] | ||
ADAMTS14 | Skin dysfunction [52] | Anti | Constitutive whole-body knockout [52] |
n.d.: not determined.
Mouse models used to study the referred ADAMTS protease in a specific disease or condition.
Immune cell type expressing the referred ADAMTS protease.
Substrate contributing to the mentioned pro/anti-inflammatory role.